MUSTANG BIO, INC. Proceeds from Issuance or Sale of Equity
MUSTANG BIO, INC. (MBIO) reported Proceeds from Issuance or Sale of Equity of $13.61 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2019-05-10
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2019-03-31 was $13.61M.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2018-12-31 was $0.00.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for the quarter ending 2018-06-30 was $0.00.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for fiscal 2017 was $50.30M, a 43.67% increase from fiscal 2016.
- MUSTANG BIO, INC. proceeds from issuance or sale of equity for fiscal 2016 was $35.01M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 7 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 10 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $13.61M 10-Q · filed 2019-05-10 | $13.61M derived: sum of 2 quarters · filed 2019-05-10 | $13.61M derived: sum of 3 quarters · filed 2019-05-10 | $13.61M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-05-10 | $62.00K derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-05-10 | $62.00K derived: sum of 3 quarters · filed 2019-05-10 | $54.00K derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $62.00K derived: sum of 2 quarters · filed 2019-03-18 | $54.00K derived: sum of 3 quarters · filed 2019-03-18 | $50.30M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $54.00K derived: sum of 2 quarters · filed 2018-11-13 | $50.30M 10-Q · filed 2018-11-13 | $74.22M derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $50.23M 10-Q · filed 2018-08-13 | $74.16M derived: sum of 3 quarters · filed 2018-08-13 | $85.24M derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $50.24M 10-Q · filed 2018-05-14 | $74.17M derived: sum of 2 quarters · filed 2018-05-14 | $85.25M derived: sum of 3 quarters · filed 2018-05-14 | $85.25M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $23.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $35.01M derived: sum of 2 quarters · filed 2018-03-29 | $35.01M derived: sum of 3 quarters · filed 2018-03-29 | $35.01M 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $11.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $11.08M derived: sum of 2 quarters · filed 2017-11-14 | $11.08M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |